DVL2 and hepatocellular carcinoma: ASPM silencing in HCC cells resulted in the decrease of Dvl2 protein level, but mRNA expression of Dvl2 and CTNNB1 (encoding β‐catenin) was unchanged (Fig. 7A), indicating that the deletion of ASPM might increase Dvl2 protein degradation.